Advertisement
Screener

AGENUS INC (AGEN) Graph

AGEN Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $34.52M; Cost of revenue $0.00; Research and development $14.76M; Net income (m).
  • 2026-03-31: Revenue $33.74M; Cost of revenue $0.00; Research and development $11.82M; Net income (m).
  • 2025-12-31: Revenue $34.20M*; Cost of revenue $0.00*; Research and development $7.51M*; Net income (m).
  • 2025-09-30: Revenue $30.23M; Cost of revenue $642.00K; Research and development $23.60M; Net income (m).

Product or service

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

AGEN revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Non CashRoyalty Revenue$28.15MNon Cash Royalty Revenue RelatedTo The Sale Of Future Royalties$28.15MPre CommercialProduct Revenue$6.37MResearch AndDevelopment Revenue$0.00Revenue$0.00Revenue$34.52MCost of revenue$0.00Operating income$11.29MOther income, net$3.38MResearch & development$14.76MNet income-$567.00K

Geography

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

AGEN revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.US$34.52MRevenue$34.52MCost of revenue$0.00Operating income$11.29MOther income, net$3.38MResearch & development$14.76MNet income-$567.00K

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueCost of revenueResearch and developmentNet income
2026-06-30$34.52M$0.00$14.76M(m)
2026-03-31$33.74M$0.00$11.82M(m)
2025-12-31$34.20M*$0.00*$7.51M*(m)
2025-09-30$30.23M$642.00K$23.60M(m)
2025-06-30$25.69M$243.00K$26.71M(m)
2025-03-31$24.07M$137.00K$21.52M(m)
2024-09-30$25.11M$146.00K$41.06M(m)
2024-06-30$23.51M$115.00K$36.77M(m)
2024-03-31$28.00M$107.00K$43.92M(m)
2023-09-30$24.31M$303.00K$51.44M(m)
2023-06-30$25.30M$254.00K$59.28M(m)
2023-03-31$22.90M$2.29M$57.12M(m)
2022-09-30$22.77M$308.00K$46.01M(m)
2022-06-30$20.93M$2.02M$44.96M(m)
2022-03-31$25.94M$543.00K$42.44M(m)
2021-09-30$252.95M$817.00K$42.94M(m)
2021-06-30$10.73M$667.00K$45.51M(m)
2021-03-31$11.72M$1.10M$36.68M(m)
2020-12-31$31.27M(m)(m)-$37.73M
2020-09-30$14.83M$911.00K$32.13M-$51.65M
2020-06-30$26.95M$634.00K$38.55M-$48.24M
2020-03-31$15.13M(m)$36.36M-$45.27M
2019-12-31$34.50M(m)(m)-$30.85M
2019-09-30$19.94M(m)$46.13M-$46.28M
2019-06-30$15.71M(m)$45.24M-$51.87M
2019-03-31$79.89M(m)$40.13M$17.43M
2018-12-31$6.45M(m)(m)-$48.85M
2018-09-30$12.80M(m)$29.85M-$33.73M
2018-06-30$15.89M(m)$29.27M-$25.20M
2018-03-31$1.64M(m)$29.44M-$54.26M
2017-12-31$8.35M(m)(m)-$35.03M
2017-09-30$3.36M(m)$25.79M-$36.84M
2017-06-30$4.21M(m)$25.82M-$31.71M
2017-03-31$26.96M(m)$32.64M-$17.10M
2016-12-31$5.58M(m)(m)-$26.12M
2016-09-30$4.45M(m)$21.59M-$40.77M
2016-06-30$6.59M(m)$22.36M-$28.32M
2016-03-31$5.96M(m)$25.04M-$31.78M
2015-12-31$7.64M(m)(m)-$15.61M
2015-09-30$6.85M(m)$18.50M-$13.12M
2015-06-30$6.38M(m)$24.77M-$40.41M
2015-03-31$3.95M(m)$9.22M-$18.74M
2014-12-31$1.62M(m)(m)-$25.98M
2014-09-30$1.56M(m)$5.28M-$8.11M
2014-06-30$3.07M(m)$5.22M-$8.04M
2014-03-31$721.00K(m)$4.47M-$357.00K
2013-12-31$393.00K(m)(m)-$5.78M
2013-09-30$736.00K(m)$3.89M-$7.32M
2013-06-30$807.00K(m)$3.32M-$11.14M
2013-03-31$1.11M(m)$2.55M-$5.83M
2012-12-31$1.09M(m)(m)-$5.44M
2012-09-30$869.00K(m)-$2.61M-$5.73M
2012-06-30$627.00K(m)-$2.91M-$6.92M
2012-03-31$13.38M(m)-$2.68M$6.77M
2011-12-31$644.00K(m)(m)-$6.02M
2011-09-30$654.00K(m)$2.53M-$5.53M
2011-06-30$786.00K(m)$2.82M-$5.76M
2011-03-31$672.00K(m)$2.82M-$5.96M
2010-09-30$624.45K(m)$2.82M-$5.71M
2010-06-30$805.17K(m)$2.63M-$4.97M

Revenue and expense 6 month

Period endRevenueCost of revenueResearch and developmentNet income
2026-06-30$68.25M$0.00$26.58M(m)
2025-06-30$49.76M$380.00K$48.23M(m)
2024-06-30$51.51M$222.00K$80.70M(m)
2023-06-30$48.20M$2.55M$116.40M(m)
2022-06-30$46.87M$2.57M$87.40M(m)
2021-06-30$22.45M$1.77M$82.18M(m)
2020-06-30$42.07M$634.00K$74.91M(m)
2019-06-30$95.61M(m)$85.37M(m)
2018-06-30$17.53M(m)$58.72M-$79.46M
2017-06-30$31.16M(m)$58.46M-$48.82M
2016-06-30$12.55M(m)$47.40M-$60.10M
2015-06-30$10.33M(m)$33.99M-$59.15M
2014-06-30$3.79M(m)$9.70M-$8.40M
2013-06-30$1.92M(m)$5.87M-$16.98M
2012-06-30$14.00M(m)-$5.59M-$155.36K
2011-06-30$1.46M(m)$5.64M-$11.72M
2010-06-30$1.74M(m)$7.26M-$13.78M

Revenue and expense 9 month

Period endRevenueCost of revenueResearch and developmentNet income
2025-09-30$79.99M$1.02M$71.83M(m)
2024-09-30$76.63M$368.00K$121.75M(m)
2023-09-30$72.51M$2.85M$167.85M(m)
2022-09-30$69.64M$2.88M$133.41M(m)
2021-09-30$275.40M$2.59M$125.12M(m)
2020-09-30$56.91M$1.54M$107.05M(m)
2019-09-30$115.55M(m)$131.51M(m)
2018-09-30$30.33M(m)$88.57M-$113.20M
2017-09-30$34.52M(m)$84.25M-$85.66M
2016-09-30$17.00M(m)$68.99M-$100.87M
2015-09-30$17.18M(m)$52.50M-$72.27M
2014-09-30$5.36M(m)$14.98M-$16.51M
2013-09-30$2.65M(m)$9.76M-$24.30M
2012-09-30$14.87M(m)-$8.19M-$5.88M
2011-09-30$2.11M(m)$8.17M-$17.26M
2010-09-30$2.37M(m)$10.08M-$19.49M

Revenue and expense 12 month

Period endRevenueCost of revenueResearch and developmentIncome taxNet income
2025-12-31$114.20M$1.02M$79.34M$0.00-$3.08M
2024-12-31$103.46M$486.00K$155.53M$0.00-$232.27M
2023-12-31$156.31M$3.11M$234.57M$0.00-$257.44M
2022-12-31$98.02M$10.57M$186.69M$0.00(m)
2021-12-31$295.67M$3.47M$178.61M$0.00(m)
2020-12-31$88.17M$2.35M$142.62M$0.00(m)
2019-12-31$150.05M(m)$168.34M$0.00(m)
2018-12-31$36.78M(m)$124.60M$0.00(m)
2017-12-31$42.88M(m)$116.13M$0.00-$120.69M
2016-12-31$22.57M(m)$94.97M$0.00-$127.00M
2015-12-31$24.82M(m)$70.44M-$5.39M-$87.88M
2014-12-31$6.98M(m)$22.35M$0.00-$42.49M
2013-12-31$3.05M(m)$13.01M$0.00-$30.07M
2012-12-31$15.96M(m)$10.56M$0.00-$11.32M
2011-12-31$2.76M(m)$11.02M$0.00-$23.28M
2010-12-31$3.36M(m)$12.88M(m)-$21.91M
2009-12-31$3.33M(m)$16.90M(m)-$30.32M

Similar stocks

Stock NameCountryMarket CapPE Ratio
C4 Therapeutics, Inc. (CCCC)United States$0.373B-5.65
FENNEC PHARMACEUTICALS INC. (FENC)United States$0.371B-115.85
Surrozen, Inc./DE (SRZN)United States$0.395B
Zura Bio Ltd (ZURA)$0.398B-6.56
Artiva Biotherapeutics, Inc. (ARTV)United States$0.367B
Cabaletta Bio, Inc. (CABA)United States$0.365B-2.81
Scribe Therapeutics, Inc. (SCTX)United States$0.410B
Ocugen, Inc. (OCGN)United States$0.343B-6.34
Editas Medicine, Inc. (EDIT)United States$0.424B-4.29
Kyverna Therapeutics, Inc. (KYTX)United States$0.434B-3.60